ChromaCode Launches High-Throughput HDPCR SARS-CoV-2 Assay
The covid-19 assay has been validated by ChromaCode, and an independent review of the validation data by FDA is pending.
Read MorePosted by | Apr 27, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The covid-19 assay has been validated by ChromaCode, and an independent review of the validation data by FDA is pending.
Read MorePosted by | Apr 27, 2020 | Emerging & Zoonotic Diseases, Infectious Diseases |
The project aims to facilitate early diagnosis and support efforts to stop the Ebola virus disease epidemic.
Read MorePosted by | Apr 24, 2020 | Covid 19, Infectious Diseases, Research |
Phase II drug trials systematically overestimate the efficacy of therapeutics, so that subsequent phase III trials often produce disappointing results.
Read MorePosted by | Apr 23, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
FDA recommends the continued use of antibody tests to help identify people who may have been exposed to the SARS-CoV-2 virus or may have recovered from the covid-19 infection.
Read MorePosted by | Apr 23, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The laboratory-based ELISA for covid-19 is expected to produce up to 46,000 results per day.
Read More